Prescriptions: Medicare Panel Backs Prostate Drug

Wednesday, November 17, 2010 - 17:10 in Health & Medicine

An advisory committee basically endorses coverage for Provenge, a treatment that costs about $93,000 a patient.

Read the whole article on NY Times Health

More from NY Times Health

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net